MRK
Merck & Co., Inc.
Cash flow statement
| USDLine, in USD | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 18.7B | 16.5B | 21.5B | 13.0B | 19.1B | — | 10.3B | 13.4B | 10.9B | 6.5B | 10.4B | 12.5B | 8.0B | 11.7B | 10.0B | 12.4B | 10.8B | 3.4B | 6.6B | 7.0B |
| 3.96B | 4.11B | 3.37B | 3.86B | 4.39B | 4.45B | 4.43B | 3.37B | 2.62B | 1.89B | 1.61B | 1.28B | 1.32B | 1.55B | 1.95B | 1.72B | 1.68B | 1.46B | 1.30B | 1.01B | |
| Free cash flow | 14.7B | 12.4B | 18.1B | 9.1B | 14.7B | — | 5.8B | 10.1B | 8.3B | 4.6B | 8.8B | 11.3B | 6.7B | 10.1B | 8.1B | 10.7B | 9.1B | 1.9B | 5.3B | 6.0B |
| Depreciation and amortization | 7.34B | 5.84B | 4.50B | 3.87B | 3.91B | 3.21B | 3.49B | 3.65B | 4.52B | 4.68B | 5.47B | 6.38B | 6.69B | 6.99B | 6.98B | 7.43B | 7.38B | 2.58B | 1.63B | 1.99B |
| Stock-based compensation | 1.06B | 0.82B | 0.76B | 0.65B | 0.54B | 0.48B | 0.44B | 0.39B | 0.35B | 0.31B | 0.30B | 0.30B | 0.28B | 0.28B | 0.34B | 0.37B | 0.51B | 0.42B | 0.35B | 0.33B |
| Buybacks | 3.54B | 5.08B | 1.31B | 1.35B | 0 | 0.84B | 1.28B | 4.78B | 9.09B | 4.01B | 3.43B | 4.19B | 7.70B | 6.52B | 2.59B | 1.92B | 1.59B | 0 | 2.73B | 1.43B |
| Dividends paid | 8.37B | 8.18B | 7.84B | 7.45B | 7.01B | 6.61B | 6.22B | 5.70B | 5.17B | 5.17B | 5.12B | 5.12B | 5.17B | 5.16B | 5.12B | 4.69B | 4.73B | 3.22B | 3.28B | 3.31B |
| Dividends per share | 3.40 | 3.28 | 3.12 | 2.96 | 2.80 | 2.64 | 2.48 | 2.26 | 1.99 | 1.89 | 1.85 | 1.81 | 1.77 | 1.73 | 1.69 | 1.56 | 1.52 | 1.52 | 1.52 | 1.52 |
| Free cash flow margin | 21.9% | 19.0% | 28.2% | 15.2% | 24.8% | — | 14.0% | 25.7% | 19.6% | 11.4% | 22.0% | — | — | — | — | — | 19.9% | 7.0% | 22.1% | 24.7% |